The future of pharmacologic treatment for bladder pain syndrome/interstitial cystitis: lessons from a meta-analysis.

[1]  R. Dmochowski,et al.  Contemporary management of the painful bladder: a systematic review. , 2012, European urology.

[2]  Zoltan Szekely,et al.  Normalization of Proliferation and Tight Junction Formation in Bladder Epithelial Cells from Patients with Interstitial Cystitis/Painful Bladder Syndrome by d‐Proline and d‐Pipecolic Acid Derivatives of Antiproliferative Factor , 2011, Chemical biology & drug design.

[3]  Ursula Wesselmann,et al.  AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. , 2011, The Journal of urology.

[4]  R. Moldwin,et al.  Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis. , 2011, The Journal of urology.

[5]  P. Dinis,et al.  Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. , 2010, European urology.

[6]  E. Lukacz,et al.  Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. , 2010, The Journal of urology.

[7]  M. Fall,et al.  Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. , 2008, European urology.

[8]  E. Rovner Intravesical Resiniferatoxin for the Treatment of Interstitial Cystitis: A Randomized, Double-Blind, Placebo Controlled Trial , 2006 .

[9]  V. Bini,et al.  Botulinum A Toxin Intravesical Injections in the Treatment of Painful Bladder Syndrome: A Pilot Study , 2006 .

[10]  T. Tammela,et al.  Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. , 2005, The Journal of urology.

[11]  K. O’Reilly,et al.  Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. , 2005, The Journal of urology.

[12]  E. Messing,et al.  A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. , 2005, The Journal of urology.

[13]  E. Messing,et al.  A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. , 2003, The Journal of urology.

[14]  Poul Jennum,et al.  The standardisation of terminology in nocturia: Report from the standardisation sub‐committee of the International Continence Society , 2002, Neurourology and urodynamics.